Added by | mollevi |
---|---|
Group name | EquipeMY |
Item Type | Journal Article |
Title | Management of colorectal peritoneal metastases: Expert opinion |
Creator | Abboud et al. |
Author | K. Abboud |
Author | M. Brunel |
Author | M. Ducreux |
Author | C. Eveno |
Author | O. Glehen |
Author | D. Goéré |
Author | J.-M. Gornet |
Author | J. H. Lefevre |
Author | P. Mariani |
Author | A. Pinto |
Author | F. Quenet |
Author | O. Sgarbura |
Author | M. Ychou |
Author | M. Pocard |
Abstract | When peritoneal metastases are diagnosed (strong agreement of experts): (i) seek advice from a multidisciplinary coordination meeting (MCM) with large experience in peritoneal disease (e.g. BIG RENAPE network); (ii) transfer (or not) the patient to a referral center with experience in hyperthermic intraperitoneal chemotherapy (HIPEC), according to the advice of the MCM. With regard to systemic chemotherapy (strong agreement of experts): (i) it should be performed both before and after surgery, (ii) for no longer than 6 months; (iii) without postoperative anti-angiogenetic drugs. With regard to cytoreductive surgery (strong agreement of experts): (i) Radical surgery requires a xiphopubic midline incision; (ii) no cytoreductive surgery via laparoscopy. With regard to HIPEC: HIPEC can be proposed for trials outside an HIPEC referral center (weak agreement between experts): (i) if surgery is radical; (ii) if the expected morbidity is "reasonable"; (iii) if the indication for HIPEC was suggested by a MCM, and; (iv) mitomycin is preferred to oxaliplatin (which cannot be recommended) for this indication. |
Publication | Journal of Visceral Surgery |
Date | Aug 26, 2019 |
Journal Abbr | J Visc Surg |
Language | eng |
DOI | 10.1016/j.jviscsurg.2019.08.002 |
ISSN | 1878-7886 |
Short Title | Management of colorectal peritoneal metastases |
Library Catalog | PubMed |
Extra | 00000 PMID: 31466831 |
Tags | Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Carcinomatosis, Chemotherapy, Cancer, Regional Perfusion, Colorectal Neoplasms, Combined Modality Therapy, Cytoreduction Surgical Procedures, Cytoreductive surgery, HIPEC, Humans, Hyperthermia, Induced, Peritoneal Neoplasms |
Date Added | 2019/09/12 - 14:15:47 |
Date Modified | 2020/08/20 - 11:05:01 |
Notes and Attachments | PubMed entry (Attachment) PubMed entry (Attachment) PubMed entry (Attachment) |